Overview
The company performs biomarker discovery using state-of-the-art proteomic screening and in-house statistical analysis with clinical trial experts. Levels Diagnostics is developing diagnostic tests for early detection of liver cancer, founded by scientists specializing in chemistry, biology, immunology, and molecular biology.
Key people
In the news
- Really looking forward to sharing the results of our latest from Levels Diagnostics at International Liver Cancer Association (ILCA) conference in Brussels this week!
- Timing is critical but very hard to control factor for every startup company! Which makes it all the better that International Liver Cancer Association (ILCA) conference is just around the corner. We just finalized the preliminary analysis of our clinical study in 300 patients and have found promising results! Our findings improve the screening for early stage liver cancer. Coen Breedveld will be sharing this results with KOL and clinicians in Brussels this week. Reach out if you want to plan a meeting! #ILCA26
Something wrong or missing? Send an update. Fixed within 24 hours.